insider.si.edu

The concept of the gene in development and evolution : historical and epistemological perspectives / edited by Peter J. Beurton, Raphael Falk, Hans-Jörg Rheinberger

The dissolution of protein coding genes in molecular biology / T. Fogle -- The differential concept of the gene: past and present / S. Schwartz -- Gene concepts and genetic concepts / F. Gifford -- ...
Science Daily

Researchers publish breakthrough study on how new genes evolve

Findings suggest that new genes can form by repurposing fragments of ancestral genes while incorporating entirely new coding regions (the protein-coding parts of the DNA). This innovative concept ...
The American Journal of Managed Care

Proof-of-Concept Study Highlights Potential of Gene-Based Therapy for Timothy Disease

The proof-of-concept study showed that antisense oligonucleotides developed by the researchers successfully restored cellular development and brain cell function in patients with the disease ...
The American Journal of Managed Care

Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study

In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy. Combining gene therapy ...
Medical Xpress

Gene or Genome: APC regulator of WNT signaling pathway

The order of cancer-driving mutations—genetic changes—plays an important role in whether tumors in the intestine can develop, new research reveals. Colorectal cancer is the second leading cause of ...
Nasdaq

PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM

VANCOUVER, BC, Dec. 4, 2023 /PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started preparations ...
Seeking Alpha

Editas Medicine Announces Strategic Transition to in vivo Gene Editing Company with Intent to Achieve Human Proof of Concept in Approximately Two Years

The Company will work closely with the clinical trial sites, regulators, and other parties to determine the path forward for patients enrolled in the RUBY and EdiTHAL trials The Company achieved in ...